This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 2002 Feb;36(2):303-4.

doi: 10.1016/s0168-8278(01)00246-x.

Hepatitis B viral genotypes and lamivudine resistance

Jia-Horng Kao, Chun-Jen Liu, Ding-Shinn Chen

PMID: 11830346
DOI: 10.1016/s0168-8278(01)00246-x

Clinical Trial

Hepatitis B viral genotypes and lamivudine resistance

Jia-Horng Kao et al. J Hepatol. 2002 Feb.

. 2002 Feb;36(2):303-4.

doi: 10.1016/s0168-8278(01)00246-x.

Authors

Jia-Horng Kao, Chun-Jen Liu, Ding-Shinn Chen

PMID: 11830346
DOI: 10.1016/s0168-8278(01)00246-x

No abstract available

PubMed Disclaimer

Similar articles

Persistence of YMDD variants after withdrawal of Lamivudine.
van der Eijk AA, Niesters HG, Pas SD, de Man RA. van der Eijk AA, et al. J Hepatol. 2002 Feb;36(2):304-5. doi: 10.1016/s0168-8278(01)00250-1. J Hepatol. 2002. PMID: 11830347 No abstract available.
Lamivudine resistant occult HBV: implications for public health?
Bowden S, Bartholomeusz A, Locarnini S. Bowden S, et al. J Hepatol. 2003 Apr;38(4):526-8. doi: 10.1016/s0168-8278(03)00079-5. J Hepatol. 2003. PMID: 12663248 Review. No abstract available.
Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns.
Honkoop P, Niesters HG, de Man RA, Osterhaus AD, Schalm SW. Honkoop P, et al. J Hepatol. 1997 Jun;26(6):1393-5. doi: 10.1016/s0168-8278(97)80476-x. J Hepatol. 1997. PMID: 9210628
[Lamivudine resistance impedes hepatitis B therapy].
Eggers HJ. Eggers HJ. Fortschr Med. 1997 Apr 30;115(12):5. Fortschr Med. 1997. PMID: 9235306 German. No abstract available.
Drug-resistant viral hepatitis.
Wright M, Main J, Thomas HC. Wright M, et al. J Infect. 2000 Jul;41(1):1-4. doi: 10.1053/jinf.2000.0658. J Infect. 2000. PMID: 10942634 Review. No abstract available.

See all similar articles

Cited by

Genetic variability in the precore and core promoter regions of hepatitis B virus strains in Karachi.
Abbas Z, Muzaffar R, Siddiqui A, Naqvi SA, Rizvi SA. Abbas Z, et al. BMC Gastroenterol. 2006 Jul 24;6:20. doi: 10.1186/1471-230X-6-20. BMC Gastroenterol. 2006. PMID: 16863587 Free PMC article.
Molecular testing in the diagnosis and management of chronic hepatitis B.
Valsamakis A. Valsamakis A. Clin Microbiol Rev. 2007 Jul;20(3):426-39, table of contents. doi: 10.1128/CMR.00009-07. Clin Microbiol Rev. 2007. PMID: 17630333 Free PMC article. Review.
Lamivudine plus tenofovir combination therapy versus lamivudine monotherapy for HBV/HIV coinfection: a meta-analysis.
Luo A, Jiang X, Ren H. Luo A, et al. Virol J. 2018 Sep 10;15(1):139. doi: 10.1186/s12985-018-1050-3. Virol J. 2018. PMID: 30201035 Free PMC article.
Evaluation of the INNO-LiPA HBV genotyping assay for determination of hepatitis B virus genotype.
Osiowy C, Giles E. Osiowy C, et al. J Clin Microbiol. 2003 Dec;41(12):5473-7. doi: 10.1128/JCM.41.12.5473-5477.2003. J Clin Microbiol. 2003. PMID: 14662927 Free PMC article.
Molecular epidemical characteristics of Lamivudine resistance mutations of HBV in southern China.
Li SY, Qin L, Zhang L, Song XB, Zhou Y, Zhou J, Lu XJ, Cao J, Wang LL, Wang J, Ying BW. Li SY, et al. Med Sci Monit. 2011 Oct;17(10):PH75-80. doi: 10.12659/msm.881965. Med Sci Monit. 2011. PMID: 21959623 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information